Summary
The time-course of plasma concentrations of the antispasticity agent tizanidine were measured by a specific radioimmune-assay in six adults who had severe spasticity due to multiple sclerosis. The drug was given as a single oral 4 mg dose to each subject. The drug had a mean absorption half-life of 0.30±0.155 h following a mean lagtime of 0.361±0.118 h, and a mean terminal elimination half-life of 4.16±2.06 h. Only 2.65±0.82% of the dose was excreted unchanged in urine in 2 h. Calculated values of clearance and apparent volume of distribution were almost certainly overestimates as it seems probable that the orally-administered drug undergoes significant presystemic elimination (its bioavailability was not determined in the investigation here reported).
Relief of spasticity, from the dosage used, was relatively slight and appeared greatest at the time of peak plasma levels of the drug.
Similar content being viewed by others
References
Brown RD, Manno JE (1978) ESTRIP, a basic computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 67: 1687–1691
Degan PH, Riess W (1976) The determination of γ-amino-β-(p-chloro-phenyl)butyric acid (baclofen) in biological materials by gas-liquid chromatography. J Chromatogr 117: 399–405
Hassan N, McLennan DL (1980) Double-blind comparison of DS 103–282, baclofen and placebo for suppression of spasticity. J Neurol Neurosurg Psychiatry 43: 1133–1136
Horowitz DL, Homer LD (1970) Analysis of biomedical data by time-sharing computers. I. Non-linear regression analysis. Project No. MR005, 20-0287. Naval Medical Research Institute, National Naval Medical Centre, Bethesda, Maryland, 20014, USA
Landau WM (1974) Spasticity: The fable of a neurological demon and the emperor's new therapy. Arch Neurol 31: 217–219
Peck CC, Barrett BB (1979) Nonlinear least-squares regression programs for microcomputers. J Pharmacokinet Biopharm 7: 537–541
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heazlewood, V., Symoniw, P., Maruff, P. et al. Tizanidine — Initial pharmacokinetic studies in patients with spasticity. Eur J Clin Pharmacol 25, 65–67 (1983). https://doi.org/10.1007/BF00544016
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00544016